TABLE 1.

Changes in RNA expression levels in 3B⁻/3C^low LCLs relative to expression levels in wild-type LCLs

Gene	Fold change in RNA levela as determined by:
	Transcriptional array	Quantitative RT-PCR
Jagged1	10.61	3.57
Neurocalcin D	6.54	5.38
Aldo-keto reductase family, member C1	3.33	1.47
Uronyl-2-sulfotransferase	2.71	1.21
Carbohydrate sulfotransferase 4	2.83	−1.37
CXCR4	2.57	12.39
Enthoprotin	2.09	6.78
Absent in melanoma 1	1.99	−1.18
PI3 kinase, p101 subunit	1.99	1.56
Transcription termination factor, RNA pol II	2.48	2.99
Vitamin A responsive	2.18	1.25
Filamin A	2.31	2.24
Pyridoxal kinase	−2.80	−1.10
Integrin α4	−4.24	−5.01
Ecotropic viral integration site 2A	−4.55	1.04
T-cell leukemia/lymphoma 1A	−8.84	−1,170.59

^aAverage change (n-fold) in RNA expression levels in 3B⁻/3C^low LCLs relative to expression levels in grouped wild-type (B95-8, P3HR1, and wild-type BAC-derived) LCLs.